Emerling received her B.A. from the University of California Santa Cruz and her PhD in molecular and cellular biology from Northwestern University. Emerling did her postdoctoral training at Harvard Medical School. She then became an Instructor of Cancer Biology in Medicine at Weill Cornell Medical College in New York City, where she continued her research on lipid kinase signaling and cancer metabolism. In August 2016, Brooke joined the faculty at Sanford Burnham Prebys Medical Discovery Institute as an Assistant Professor in the Cancer Metabolism and Signaling Networks Program.
Funding Awards and Collaborative Grants
Breast Cancer Research Foundation – AACR Career Development Award for Translational Breast Cancer Research
Mary Kay Foundation Innovative Translational Grant Award
Department of Defense Breast Research Program Breakthrough Award
Honors and Recognition
2014: NextGen Star – AACR Early-Career Speaker Award
2013-2016: Mastercard Ajay Banga Scientist Award
2013: AACR – Aflac Travel Fellowship Award
Related Disease
Breast Cancer, Cancer
Phenomena or Processes
Cancer Biology, Cancer Metabolism, Cell Signaling, Metabolic Processes, Signal Transduction
Research in the Emerling Lab is focused on understanding key signaling and metabolic pathways involved in the regulation of cellular function under pathological conditions such as cancer. Our research program centers around dissecting the roles of the family of non-canonical phosphatidylinositol kinases, called the phosphatidylinositol-5-phosphate 4-kinases (PI5P4Ks), in cancer metabolism using a multi-disciplinary approach integrating human, mouse, and worm models. Currently, a major research project in the Emerling Lab is determining the role of the PI5P4Ks in p53 mutant cancers, especially the triple-negative breast cancer subgroup where targeted therapies have not been effective.
Feb 12, 2025Curebound awards two grants to Sanford Burnham Prebys scientists
Feb 12, 2025The San Diego-based philanthropic organization has awarded $43 million in cancer research to date.
Oct 18, 2024Two Sanford Burnham Prebys scientists selected for American Cancer Society postdoctoral fellowships
Oct 18, 2024The funds will support Alicia Llorente Lope and Ambroise Manceau who study breast and pancreatic cancer.
May 28, 2024Overlooked lipid connected to ancient cellular pathway with links to cancer
May 28, 2024Scientists at Sanford Burnham Prebys and Vanderbilt University uncover a new role for a neglected lipid that may play a…
Feb 3, 2023New treatment approach for prostate cancer could stop resistance in its tracks
Feb 3, 2023By inhibiting one enzyme, scientists from Sanford Burnham Prebys can kill prostate cancer cells when other treatments can’t For the
Jun 30, 2022Three Sanford Burnham Prebys faculty receive promotions
Jun 30, 2022The promoted faculty, all from the Institute’s NCI-designated Cancer Center, include Ani Deshpande, PhD, Brooke Emerling, PhD and Charles Spruck,…
Jun 27, 2022Brooke Emerling awarded $2.3 million to demystify breast cancer metabolism
Jun 27, 2022After a promising breakthrough in cancer metabolism, the NIH is helping Sanford Burnham Prebys keep up the good work Brooke…